| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 10.439 | 127.204 | 349.091 | 523.062 | 458.893 | 502.665 | 657.602 |
| Total Income - EUR | - | - | - | 10.793 | 127.588 | 350.919 | 526.383 | 464.924 | 507.264 | 659.357 |
| Total Expenses - EUR | - | - | - | 10.558 | 89.941 | 271.245 | 416.780 | 388.739 | 470.582 | 571.315 |
| Gross Profit/Loss - EUR | - | - | - | 234 | 37.647 | 79.673 | 109.603 | 76.186 | 36.683 | 88.042 |
| Net Profit/Loss - EUR | - | - | - | 127 | 36.466 | 76.877 | 105.204 | 72.280 | 32.243 | 75.005 |
| Employees | - | - | - | 1 | 1 | 2 | 2 | 2 | 3 | 1 |
Check the financial reports for the company - Rs Medical Line S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 5.206 | 12.453 | 9.740 | 26.163 | 17.060 | 13.584 |
| Current Assets | - | - | - | 8.037 | 42.672 | 143.094 | 173.320 | 247.902 | 222.548 | 306.004 |
| Inventories | - | - | - | 1.322 | 8.140 | 37.234 | 27.775 | 76.259 | 69.448 | 57.624 |
| Receivables | - | - | - | 3.764 | 24.969 | 74.775 | 88.113 | 85.215 | 62.789 | 165.343 |
| Cash | - | - | - | 2.951 | 9.564 | 31.085 | 57.431 | 86.427 | 90.312 | 83.037 |
| Shareholders Funds | - | - | - | 170 | 36.632 | 76.960 | 105.310 | 121.864 | 32.331 | 75.091 |
| Social Capital | - | - | - | 43 | 42 | 74 | 73 | 73 | 73 | 72 |
| Debts | - | - | - | 7.868 | 11.246 | 78.588 | 77.750 | 152.201 | 202.262 | 244.695 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 6.144 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Rs Medical Line S.r.l.